Archive · 25 Jun 2025
Wegovy and Mounjaro: New Weight Loss Drugs in India
Two new weight-loss medicines, Wegovy and Mounjaro, are now available in India.
They work by mimicking hormones to control blood sugar and appetite, helping people lose a significant amount of weight, similar to some surgeries.
They also have other health benefits, such as improving heart and liver health.
They can cause side effects like nausea, and aren't suitable for everyone.
To get the best results, these drugs should be taken with a healthy diet and exercise.
Long-term use might be needed to keep the weight off.
Wegovy and Mounjaro are injectable weight loss therapies available in India.
These drugs can help users lose 15-20% of their body weight.
GLP-1 receptor agonists, like Wegovy's semaglutide, mimic gut hormones for blood sugar and appetite control.
Both drugs have benefits for other health conditions, including cardiovascular diseases.
They may be muscle-protective but should be used with diet and exercise.
- Who
- People with obesity
- What
- Wegovy and Mounjaro are new weight loss drugs available in India.
- When
- Present
- Where
- India
- Why
- To address obesity and related health issues.
Patients
Medical Concerns
Drug effectiveness
Patients
Can benefit from weight loss drugs.
Medical Concerns
Potential for side effects and uncertainty on long term usage.
- Drugs Mentioned
- Wegovy, Mounjaro
- Active Ingredient (Wegovy)
- Semaglutide
- Administration
- Injectable
- Weight Loss Percentage
- 15-20%
- Potential Benefits
- Cardiovascular and liver health
- Potential Side Effects
- Nausea, vomiting
Sources
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
Wegovy, the global weight loss drug, launched in India: How much will it cost?
Novo Nordisk Launches Anti-obesity Drug Wegovy in India
Novo Nordisk Launches Weight-loss Drug Wegovy in India; How Does It Work?
Novo Nordisk eyes Rs 8,600 crore India sales with weight-loss drug Wegovy
Wegovy launched in India: How the breakthrough drug triggers weight loss
Weight loss drug Wegovy launched in India. How different is it from Lilly's Mounjaro? Check cost, other details
Novo Nordisk Debuts Weight Loss Drug Wegovy In India, Starting At Rs 4,300: Country Chief To News18
India gets Wegovy jab to fight obesity and heart risk, priced at Rs 17,345–26,050/month
Novo Nordisk launches weight loss drug Wegovy priced at ₹ 17,345 per month
Novo Nordisk stirs up the weightloss drugs segment in India with Wegovy
